Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Takeda
Nuvation Bio Inc.
Tempus AI
Incyte Corporation
Actym Therapeutics, Inc.
University of Southern California
University of Virginia
National Institutes of Health Clinical Center (CC)
NRG Oncology
Black Diamond Therapeutics, Inc.
Elevation Oncology
Valerio Therapeutics
Tango Therapeutics, Inc.
Pfizer
Medikine, Inc.
Ikena Oncology
Haihe Biopharma Co., Ltd.
OHSU Knight Cancer Institute
Atreca, Inc.
Fusion Pharmaceuticals Inc.
Leap Therapeutics, Inc.
Centre Hospitalier Universitaire de Besancon
Centre Georges Francois Leclerc
pharmaand GmbH
Hoffmann-La Roche
Nuvation Bio Inc.
Eastern Cooperative Oncology Group
West Virginia University
Duke University
National Institutes of Health Clinical Center (CC)
MacroGenics
ADC Therapeutics S.A.
Advanced Accelerator Applications
National Institutes of Health Clinical Center (CC)
Tetra Bio-Pharma
InSightec
Cambridge University Hospitals NHS Foundation Trust
Scripps Translational Science Institute
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Wisconsin, Madison
Vanderbilt-Ingram Cancer Center
Seagen Inc.
Yale University
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
CureOne
National Institutes of Health Clinical Center (CC)